Characterization of Germ Cell Cancer Cell lines resistant to Cisplatin. Germ Cell Cancer Characterization
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
later
应用场景：
创建时间：
2022-06-02
相关数据集
An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells [BiSulfite-seq]
Long noncoding RNAs are critical regulators of cell biology whose alteration can lead to the development of diseases such as cancer. The potential role of lncRNAs and their epigenetic regulation in re
NIAID Data Ecosystem80
SMARCA4 loss-of-function induces cisplatin resistance to activate YAP1-dependent epithelial-to-mesenchymal in triple negative breast cancer
We report transcriptome profiling (RNA-seq) for SMARA4 knock-out to elucidate the association with cisplatin-resistance and SMARCA4 loss-of-function using triple negative breast cancer cell lines. Ove
NIAID Data Ecosystem50
TFAP2A upregulates SKA3 to promote glycolysis and reduce the sensitivity of lung adenocarcinoma cells to cisplatin
Supplementary data for the article
NIAID Data Ecosystem10
Additional file 2 of Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma
Supplementary Material 2. Table 2. Univariate regression analysis of cisplatin-resistance and non-resistance LUAD cohorts.
Figshare2024-08-15 更新50
Genome-wide methylation and expression profiling study identifies candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer.
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
NIAID Data Ecosystem40
